ABN Report
Genomefrontier Therapeutics Au Pty Ltd ABN Report
Genomefrontier Therapeutics Au Pty Ltd (ABN 46 671 468 572) an Australian Private Company with an address in Victoria has had an active ABN from Friday, 15th September 2023 and is registered for GST.
Name:
Genomefrontier Therapeutics Au Pty Ltd
ABN:
46 671 468 572
Status:
ABN Active
from 15 September 2023
Type:
Australian Private Company
ACN:
671 468 572
GST:
Registered for GST
from 15 September 2023
Location:
Melbourne, Inner City,
VIC
, 3000
ABN Updated:
29 September 2023
ATLAS MARITIME PTY LTD
The Trustee for JHF Family Trust